Diabetes

New immunotherapy trial for Type 1 diabetes

The search for a treatment for Type 1 diabetes (T1D) - which affects over 400,000 people in the UK – will be stepped up with the start of a new phase one clinical trial at Guy's Hospital in London.

Neuroscience

Multiple sclerosis: Damaged myelin not the trigger

Damaged myelin in the brain and spinal cord does not cause the autoimmune disease multiple sclerosis (MS), neuroimmunologists from the University of Zurich have now demonstrated in collaboration with researchers from Berlin, ...

Diabetes

Researchers dig for cause of dog diabetes

(HealthDay)—Like many other animals, man's best friend isn't immune to developing diabetes. But new research suggests that while the disease in dogs looks similar to type 1 diabetes in people, there are some significant ...

Diabetes

Clinical trial for type 1 diabetes begins at JGH, MUHC

Investigators at Montreal's Lady Davis Institute at the Jewish General Hospital and McGill University Health Centre have announced the start of a landmark clinical study aimed at restoring normal insulin secretion in people ...

Diabetes

Solving a genetic mystery in type 1 diabetes

In type 1 diabetes, the immune system attacks the body's own insulin-producing cells. Scientists understand reasonably well how this autoimmune attack progresses, but they don't understand what triggers the attack or how ...

Diseases, Conditions, Syndromes

Drug prevents multiple sclerosis relapses in phase 3 trial

A newly completed phase 3, multicenter clinical trial has found that an immune-modulating drug can silence inflammatory disease activity in a large majority of patients with relapsing multiple sclerosis (RMS)—the most common ...

Medical research

Gene therapy reverses type 1 diabetes in mice

An experimental cure for Type 1 diabetes has a nearly 80 percent success rate in curing diabetic mice. The results, to be presented Saturday at The Endocrine Society's 93rd Annual Meeting in Boston, offer possible hope of ...

page 1 from 6